Nonetheless, this model, like other genetic models of NAFLD, can be criticized for a lack of evidence for genetic mutations in the human CEACAM1 gene that correlate with NAFLD, T2D, or CVD. The gene discussed is CEACAM1; the disease is metabolic dysfunction-associated steatotic liver disease.